Patients who took popular weight loss drugs were 12 per cent less likely to develop Alzheimer’s disease but were more at risk of arthritic, kidney and pancreatic disorders, according to the largest ever study of the medicines’ widening impact.
A cohort of 215,000 US military veterans with diabetes who used so-called GLP-1 treatments showed lower health risk for 42 condition and a higher risk for 19 others, compared with those who took older medicines.
您已阅读14%（566字），剩余86%（3529字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。